High prevalence of germline TP53 mutations in young osteosarcoma cases

被引:2
|
作者
Mirabello, Lisa J. [1 ]
Yeager, Meredith [2 ]
Mai, Phuong L. [1 ]
Gastier-Foster, Julie [3 ,4 ]
Gorlick, Richard [5 ]
Khanna, Chand [6 ]
Patino-Garcia, Ana [7 ]
Sierrasesumaga, Luis [7 ]
Lecanda, Fernando [7 ]
Andrulis, Irene L. [8 ]
Wunder, Jay S. [8 ]
Gokgoz, Nalan [8 ]
Barkauskas, Donald A. [9 ]
Zhang, Xijun [2 ]
Vogt, Aurelie [2 ]
Jones, Kristine [2 ]
Boland, Joseph F. [2 ]
Chanock, Stephen J. [1 ]
Savage, Sharon A. [1 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[2] Leidos Biomed Res, Frederick Natl Lab Canc Res, Frederick, MD USA
[3] Nationwide Childrens Hosp, Columbus, OH USA
[4] Ohio State Univ, Dept Pathol & Pediat, Columbus, OH 43210 USA
[5] Childrens Hosp, Albert Einstein Coll Med, Montefiore, NY USA
[6] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[7] Univ Navarra, Univ Navarra Clin, Dept Pediat, E-31080 Pamplona, Spain
[8] Univ Toronto, Litwin Ctr Canc Genet, Lunenfeld Tanenbaum Res Inst, Mt Sinai Hosp, Toronto, ON M5S 1A1, Canada
[9] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA
关键词
D O I
10.1158/1538-7445.AM2015-5574
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5574
引用
下载
收藏
页数:3
相关论文
共 50 条
  • [31] TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma
    Andrade, Raissa C.
    de Lima, Maria A. F. D.
    de Faria, Paulo A. S.
    Vargas, Fernando R.
    FAMILIAL CANCER, 2018, 17 (01) : 119 - 122
  • [32] TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma
    Raissa C. Andrade
    Maria A. F. D. de Lima
    Paulo A. S. de Faria
    Fernando R. Vargas
    Familial Cancer, 2018, 17 : 119 - 122
  • [33] Characterization of germline TP53 splicing mutations and their genetic and functional analysis
    J M Varley
    C Attwooll
    G White
    G McGown
    M Thorncroft
    A M Kelsey
    M Greaves
    J Boyle
    J M Birch
    Oncogene, 2001, 20 : 2647 - 2654
  • [34] Germline TP53 mutations: the predominant genetic cause of adrenocortical carcinoma
    Renaux-Petel, M.
    Charbonnier, F.
    Tournier, I.
    Lienard, G.
    Bou, J.
    Kasper, E.
    Leheup, B.
    Mansuy, L.
    Guerrini-Rousseau, L.
    Brugieres, L.
    Liard-Zmuda, A.
    Baert-Desurmont, S.
    Frebourg, T.
    Bougeard, G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1105 - 1105
  • [35] NO GERMLINE TP53 MUTATIONS DETECTED IN FAMILIAL AND BILATERAL TESTICULAR CANCER
    HEIMDAL, K
    LOTHE, RA
    LYSTAD, S
    HOLM, R
    FOSSA, SD
    BORRESEN, AL
    GENES CHROMOSOMES & CANCER, 1993, 6 (02): : 92 - 97
  • [36] Cutaneous pleomorphic fibromas arising in patients with germline TP53 mutations
    Cloutier, Jeffrey M.
    Shalin, Sara C.
    Lindberg, Matthew
    Gardner, Jerad M.
    Fernandez-Pol, Sebastian
    Zaba, Lisa
    Novoa, Roberto
    Brown, Ryanne A.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (08) : 734 - 741
  • [37] Relative frequency and morphology of cancers in carriers of germline TP53 mutations
    Birch, JM
    Alston, RD
    McNally, RJQ
    Evans, DGR
    Kelsey, AM
    Harris, M
    Eden, OB
    Varley, JM
    ONCOGENE, 2001, 20 (34) : 4621 - 4628
  • [38] Drastic Effect of Germline TP53 Missense Mutations in LiFraumeni Patients
    Zerdoumi, Yasmine
    Aury-Landas, Juliette
    Bonaiti-Pellie, Catherine
    Derambure, Celine
    Sesbouee, Richard
    Renaux-Petel, Mariette
    Frebourg, Thierry
    Bougeard, Gaelle
    Flaman, Jean-Michel
    HUMAN MUTATION, 2013, 34 (03) : 453 - 461
  • [39] Characterization of germline TP53 splicing mutations and their genetic and functional analysis
    Varley, JM
    Attwooll, C
    White, G
    McGown, G
    Thorncroft, M
    Kelsey, AM
    Greaves, M
    Boyle, J
    Birch, JM
    ONCOGENE, 2001, 20 (21) : 2647 - 2654
  • [40] Relative frequency and morphology of cancers in carriers of germline TP53 mutations
    Jillian M Birch
    Robert D Alston
    Richard JQ McNally
    D Gareth R Evans
    Anna M Kelsey
    Martin Harris
    Osborn B Eden
    Jennifer M Varley
    Oncogene, 2001, 20 : 4621 - 4628